TCL Archive Nevins Retracts Key Paper By Duke Group, Raising Question Of Harm To Patients October 29, 2010
TCL Archive In Brief: Thomas Davis Is Named New Director Of NCCP; Senate Subcommittee Give NCI $1.2 Bil. For FY ‘86 September 27, 1985
TCL Archive Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer February 29, 2008
